Last year proved to be a challenging one. The Growth portfolio produced a total return of 12.6 per cent compared with 15.9 per cent for the MSCI PIMFA Growth index. Meanwhile, the Income portfolio returned 9.6 per cent compared with 10.4 per cent for the MSCI PIMFA Income index. As usual, all performance figures are calculated on a total return basis and portfolio figures include all costs.
The portfolios have always invested with the long term in view. While never complacent, total returns since their inception in 2009 have been 455.2 per cent and 303.8 per cent, which compares with index returns of 229.4 per cent and 165.9 per cent, respectively. Meanwhile, at year-end, the portfolios were yielding 2.8 per cent and 3.5 per cent, respectively. The tables below provide further detail.
For a variety of reasons, the investment trust sector in general lagged the market – rising just over 10 per cent compared with 17 per cent for the FTSE All World Index. Such occasional headwinds remind investors that short-term volatility is usually the price worth paying to benefit from investment trusts’ superior performance relative to indices and open-ended funds over time.
As highlighted in previous columns, given the determination of governments to engineer a strong economic recovery, the extent of quantitative easing (QE), the prospect of interest rates remaining artificially low, and the valuation contrast between many ‘growth’ and ‘value’ companies, the portfolios continued to reduce the extent of their overweight positions in growth companies after a strong run in recent years, in order to ensure a better balance within their equity exposure.
However, as regular readers know, the rebalancing between the two styles was also matched by the portfolios adopting a more ‘defensive’ asset allocation as the year progressed, in order to ensure balance relative to remit. This involved increasing exposure to other asset classes including specialist debt and renewable energy infrastructure, which also assisted with income levels.
Otherwise, the portfolios’ minimal Asia Pacific and emerging markets exposure and more substantial healthcare exposure detracted from overall performance. I remain positive regarding the latter. Overweight positions in UK smaller companies, commodities, commercial property and private equity assisted performance and helped to compensate somewhat for the wider sector’s modest relative performance.
As for 2022, recent columns have referred to concerns about inflation proving more than transitory, and to the rationale of remaining overweight the UK and smaller companies, private equity and the healthcare sector within their equity exposure. Commodities, commercial property, infrastructure and higher-yielding corporate bonds remain favoured when it comes to other assets. Future columns will highlight other preferences and nuances.
However, while continuing to seek attractive returns, it will also be important to remain committed to tried-and-tested investment disciplines and principles in what will be an increasingly volatile period in the markets. Stretched valuations in certain sectors, market leadership being decided, the policy response to rising inflation, the possibility of QE being wound down and increasing geopolitical tensions are just some of the testing issues markets will grapple with this year.
Particularly at such times, it is important to focus on the long term. The column’s portfolios pay little attention to short-term market ‘noise’. The most important determinant is always the ability of companies to create wealth and add value over time, and the conditions that sustain such an environment. The focus remains on assessing the extent of disconnect between sentiment and fundamentals, and volatility is therefore seen as an opportunity.
The portfolios tend to remain invested and seek to add value over time – wiser investors are left to time the markets. Such an approach also allows the full harvesting of dividends, which become an increasingly important contributor to total returns over time – the portfolios’ higher yield, relative to benchmark, acknowledging the significant contribution made by reinvested income to overall returns.
These disciplines will continue to guide the management of all nine (soon to be 10) real investment trust portfolios on the website www.johnbaronportfolios.co.uk, including the two regularly covered in this monthly column. It helps them achieve a broad range of risk-adjusted strategies and income levels with yields of up to 5.1 per cent.
Five of these portfolios represent an investment journey that becomes increasingly defensive as financial goals come into view. This helps to highlight the importance of rebalancing and diversification as a means of helping to protect past gains – both being essential but undervalued disciplines. This usually involves increasing exposure to assets less correlated to equities, including bonds, infrastructure, renewable energy, commercial property and specialist debt – which further assist with income levels.
Furthermore, and most importantly, investment is best kept simple to succeed. Complexity usually adds cost, risks confusion and hinders performance. The portfolios therefore avoid structured products, hedge funds, derivatives, options, etc and instead focus on what we know and our fundamental belief in the power of well-chosen equities to produce superior returns over the long term.
Such investment disciplines and pointers have stood the test of time and will continue to guide us through choppy waters.
Over the past three months of the year, the Growth portfolio reduced its exposure to Finsbury Growth & Income Trust (FGT) and JPMorgan Japan Smaller Growth & Income (JSGI), and sold TR Property (TRY). With the monies raised, Personal Assets Trust (PNL) and JLEN Environmental Assets Group (JLEN) were introduced, and Standard Life Property Income (SLI) and AVI Global Trust (AGT) added to.
These changes were essentially defensive in nature by reducing exposure to equities (FGT, JSGI) or shares in property companies (TRY), while increasing exposure to other assets (PNL, JLEN) and to a trust that invests directly in commercial property (SLI). As previous columns have indicated, it is important to ensure portfolios remain balanced relative to remit, particularly after markets have enjoyed a strong run. Meanwhile, the rebalancing between growth and value continued – as evidenced by the increased exposure to AGT.
Meanwhile, the Income portfolio reduced its exposure to Montanaro UK Smaller Companies (MTU), Edinburgh Worldwide (EWI) and CQS Natural Resources Growth & Income (CYN), and sold BMO UK High Income (BHI). With the cash raised, Apax Global Alpha Ltd (APAX) was introduced, and exposure increased to Edinburgh Investment Trust (EDIN), The Mercantile Trust (MRC) and JLEN Environmental Assets Group (JLEN).
The reasons for these changes were more nuanced. The sales reflected recognition of strong runs (MTU, CYN) and narrow discounts relative to prospects (EWI, BHI). The equity purchases factored in attractive discounts relative to performance and outlook (APAX, MRC), and improving prospects (EDIN). The purchase of JLEN was more defensive in nature and continued the work of previous quarters.
|1 Jan 2009 – 31 Dec 2021|
|Year to 31 Dec 2021|
|*The MSCI PIMFA Growth and Income benchmarks are cited (total return)|
|Portfolio breakdowns for column 14 January 2022|
|(Performance figures since inception and for 2021 are given in the column's accompanying Word document)|
|Portfolio breakdowns as at 31 December 2021|
|Growth Portfolio||Income Portfolio|
|CQS New City High Yield (NCYF)||4.5%||iShares Index Linked Gilts ETF (INXG)||5.5%|
|iShares Index Linked Gilts ETF (INXG)||2.5%||Henderson Diversified Income (HDIV)||3.0%|
|UK Shares||CQS New City High Yield (NCYF)||2.5%|
|Murray Income Trust (MUT)||5.0%||UK Shares|
|Edinburgh Investment Trust (EDIN)||4.0%||Dunedin Income Growth (DIG)||5.5%|
|The Mercantile Trust (MRC)||3.5%||The Mercantile Trust (MRC)||4.5%|
|Henderson Smaller Companies (HSL)||3.5%||Edinburgh Investment Trust (EDIN)||4.5%|
|Aberdeen UK Smaller Cos (SLS)||3.5%||Invesco Perpetual UK Smaller Cos (IPU)||4.0%|
|Montanaro UK Smaller Cos (MTU)||3.0%||Montanaro UK Smaller Cos (MTU)||3.0%|
|Finsbury Growth & Income Trust (FGT)||2.5%||Aberforth Split Level Income (ASIT)||2.5%|
|BlackRock Throgmorton Trust (THRG)||2.5%||International Shares|
|Aberforth Split Level Income (ASIT)||2.0%||Murray International Trust (MYI)||4.5%|
|International Shares||Smithson Investment Trust (SSON)||3.5%|
|AVI Global Trust (AGT)||4.5%||Utilico Emerging Markets (UEM)||2.5%|
|Baillie Gifford US Growth Trust (USA)||4.0%||Edinburgh Worldwide (EWI)||2.0%|
|Monanaro European Smaller Cos (MTE)||3.0%||Themes|
|Oryx International Growth Fund (OIG)||2.5%||Herald (HRI)||4.5%|
|JPMorgan Japan Smaller Cos (JPS)||2.0%||Apax Global Alpha Ltd (APAX)||4.0%|
|Edinburgh Worldwide (EWI)||2.0%||Personal Assets Trust (PNL)||3.5%|
|Themes||BB Healthcare (BBH)||2.5%|
|Herald (HRI)||4.5%||Ruffer Investment Company (RICA)||2.5%|
|BB Healthcare (BBH)||3.5%||Other Assets|
|Standard Life Private Equity Trust (SLPE)||3.5%||Standard Life Property Income (SLI)||5.0%|
|Personal Assets Trust (PNL)||3.0%||BioPharma Credit Investments (BPCR)||5.0%|
|Worldwide Healthcare Trust (WWH)||2.5%||HICL Infrastructure Company (HICL)||4.5%|
|Augmentum Fintech (AUGM)||2.5%||JLEN Environmental Assets Group (JLEN)||4.0%|
|Apax Global Alpha Ltd (APAX)||2.5%||BlackRock World Mining (BRWM)||3.5%|
|Other Assets||WisdomTree Physical Gold ETF £ (PHGP)||3.0%|
|Standard Life Property Income (SLI)||5.0%||Regional REIT (RGL)||2.5%|
|HICL Infrastructure Company (HICL)||5.0%||CQS Natural Resources Growth & Inc (CYN)||2.5%|
|BioPharma Credit Investments (BPCR)||4.0%||International Public Partnerships (INPP)||2.5%|
|BlackRock World Mining (BRWM)||3.5%||GCP Asset Backed Income Fund (GABI)||2.0%|
|JLEN Environmental Assets Group (JLEN)||3.0%|
|CQS Natural Resources Growth & Inc (CYN)||2.0%|
|Holdings are rounded to the nearest 0.5%|